These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32599469)

  • 1. Saliva immunoglobulin free light chain analysis for monitoring disease activity and response to treatment in multiple sclerosis.
    Lotan I; Ganelin-Cohen E; Tartakovsky E; Khasminsky V; Hellmann MA; Steiner I; Ben-Zvi I; Livneh A; Golderman S; Kaplan B
    Mult Scler Relat Disord; 2020 Sep; 44():102339. PubMed ID: 32599469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized Disease Monitoring in Pediatric Onset Multiple Sclerosis Using the Saliva Free Light Chain Test.
    Ganelin-Cohen E; Tartakovsky E; Klepfish E; Golderman S; Rozenberg A; Kaplan B
    Front Immunol; 2022; 13():821499. PubMed ID: 35450065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin free light chains in saliva: a potential marker for disease activity in multiple sclerosis.
    Kaplan B; Golderman S; Ganelin-Cohen E; Miniovitch A; Korf E; Ben-Zvi I; Livneh A; Flechter S
    Clin Exp Immunol; 2018 Apr; 192(1):7-17. PubMed ID: 29194592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free light chain monomer-dimer patterns in the diagnosis of multiple sclerosis.
    Kaplan B; Golderman S; Yahalom G; Yeskaraev R; Ziv T; Aizenbud BM; Sela BA; Livneh A
    J Immunol Methods; 2013 Apr; 390(1-2):74-80. PubMed ID: 23376556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The association of intrathecal production of immunoglobulin free light chains and progression of multiple sclerosis].
    Makshakov GS; Nazarov VD; Totolyan NA; Lapin SV; Mazing AV; Emanuel VL; Krasnov VS; Shumilina MV; Skoromets AA; Evdoshenko EP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10. Vyp. 2):4-10. PubMed ID: 29359727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations of immunoglobulin free light chains in cerebrospinal fluid predict increased level of brain atrophy in multiple sclerosis.
    Nazarov V; Makshakov G; Kalinin I; Lapin S; Surkova E; Mikhailova L; Gilburd B; Skoromets A; Evdoshenko E
    Immunol Res; 2018 Dec; 66(6):761-767. PubMed ID: 30635824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis.
    Makshakov G; Nazarov V; Kochetova O; Surkova E; Lapin S; Evdoshenko E
    PLoS One; 2015; 10(11):e0143375. PubMed ID: 26606531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
    Voortman MM; Stojakovic T; Pirpamer L; Jehna M; Langkammer C; Scharnagl H; Reindl M; Ropele S; Seifert-Held T; Archelos JJ; Fuchs S; Enzinger C; Fazekas F; Khalil M
    Mult Scler; 2017 Oct; 23(11):1496-1505. PubMed ID: 27899552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Search for new biomarkers of pediatric multiple sclerosis: application of immunoglobulin free light chain analysis.
    Ganelin-Cohen E; Golderman S; Yeskaraev R; Rozenberg A; Livneh A; Kaplan B
    Clin Chem Lab Med; 2018 Jun; 56(7):1081-1089. PubMed ID: 29408796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal synthesis of free immunoglobulin light chains in multiple sclerosis.
    Krakauer M; Schaldemose Nielsen H; Jensen J; Sellebjerg F
    Acta Neurol Scand; 1998 Sep; 98(3):161-5. PubMed ID: 9786611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free light chain monomers in the diagnosis of multiple sclerosis.
    Kaplan B; Aizenbud BM; Golderman S; Yaskariev R; Sela BA
    J Neuroimmunol; 2010 Dec; 229(1-2):263-71. PubMed ID: 20870296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity-a cohort study.
    Hegen H; Berek K; Bsteh G; Auer M; Altmann P; Di Pauli F; Grams A; Milosavljevic D; Ponleitner M; Poskaite P; Schnabl C; Wurth S; Zinganell A; Berger T; Walde J; Deisenhammer F
    EBioMedicine; 2023 May; 91():104573. PubMed ID: 37086651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free light chains in the cerebrospinal fluid. Comparison of different methods to determine intrathecal synthesis.
    Hegen H; Walde J; Milosavljevic D; Aboulenein-Djamshidian F; Senel M; Tumani H; Deisenhammer F; Presslauer S
    Clin Chem Lab Med; 2019 Sep; 57(10):1574-1586. PubMed ID: 31112501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid sequence homology of monoclonal serum free light chain dimers and tissue deposited light chains in AL amyloidosis: a pilot study.
    Goldis R; Kaplan B; Arad M; Dispenzieri A; Dasari S; Kukuy OL; Simon AJ; Dori A; Shavit-Stein E; Ziv T; Murray D; Kourelis T; Gertz MA; Dominissini D; Magen H; Muchtar E
    Clin Chem Lab Med; 2024 Feb; 62(3):464-471. PubMed ID: 37747270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of cerebrospinal fluid kappa free light chains with the intrathecal polyspecific antiviral immune response in multiple sclerosis.
    Huss A; Mojib-Yezdani F; Bachhuber F; Fangerau T; Lewerenz J; Otto M; Tumani H; Senel M
    Clin Chim Acta; 2019 Nov; 498():148-153. PubMed ID: 31437445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort.
    Senel M; Mojib-Yezdani F; Braisch U; Bachhuber F; Lewerenz J; Ludolph AC; Otto M; Tumani H
    Front Immunol; 2019; 10():641. PubMed ID: 30984199
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analysis of serum free light chains κ/λ ratio and heavy/light chain pairs of immunoglobulin to the stratification of multiple myeloma according to Mayo Stratification of Myeloma and Revised International Staging System].
    Ščudla V; Balcárková J; Lochman P; Vincová M; Pika T; Minařík J; Zapletalová J; Jarošová M
    Vnitr Lek; 2016 Apr; 62(4):269-80. PubMed ID: 27250604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Intrathecal Free Light Chain Synthesis: Comparison of Different Quantitative Methods with the Detection of Oligoclonal Free Light Chains by Isoelectric Focusing and Affinity-Mediated Immunoblotting.
    Zeman D; Kušnierová P; Švagera Z; Všianský F; Byrtusová M; Hradílek P; Kurková B; Zapletalová O; Bartoš V
    PLoS One; 2016; 11(11):e0166556. PubMed ID: 27846293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The content of free light-chain immunoglobulins in the cerebrospinal fluid and the importance of its determination for the differential diagnosis of multiple sclerosis].
    Totolian NA; Griazeva IV; Klimovich VB; Skoromets AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(2):49-53. PubMed ID: 7941891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid immunoglobulin light chain ratios predict disease progression in multiple sclerosis.
    Rathbone E; Durant L; Kinsella J; Parker AR; Hassan-Smith G; Douglas MR; Curnow SJ
    J Neurol Neurosurg Psychiatry; 2018 Oct; 89(10):1044-1049. PubMed ID: 29743290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.